IDF21-0686 Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM

Category Systematic review
JournalDiabetes Research and Clinical Practice
Year 2022
This article has no abstract
Epistemonikos ID: 764a1c75533caa05b11baba8be31e428676119d5
First added on: Feb 14, 2025